Supply Chain Ecosystem Analysis now part of DBMR Reports
Global Counterfeit Drug Detection Device Market, By Product (Counterfeit Chemical Composition Detection Devices, Counterfeit Packaging and Labelling Detection Devices), Modality (Portable Devices, Handheld Devices, Benchtop Devices), End Use (Pharmaceutical Companies, Drug Testing Laboratories, Research Organizations, Others), Drug Assessment (Oral Pill, Injectable, Inhalable, Topical, Eye Drop), Therapeutic Assessment (Alimentary, Anti-Infectives, Blood Agents, Cardiovascular, Central Nervous System, Cytostatics, Dermatological, Genitourinary, Hormones, Hospital Solutions, Metabolism, Musculoskeletal, Respiratory, Other Parasitology, and Sensory Organs) – Industry Trends and Forecast to 2029.
Counterfeit drugs is one of the greatest challenges faced by the healthcare institutions and pharmaceuticals manufacturers. Counterfeit drugs and medical equipment are available at a large scale in the market, thereby hampering the goodwill of the market. As a result, there emerged a strong demand for efficient detection systems. This led to the introduction of counterfeit drug detection devices in the market.
Data Bridge Market Research analyses that the counterfeit drug detection device market is expected to undergo a CAGR of 4.80% during the forecast period. “Handheld Devices” accounts for the largest modality segment in the counterfeit drug detection device market owing to the rising adoption of these devices due to an integrated flexible user interface, ergonomic design, and longer battery life.
Counterfeit drug detection devices are the products that are effective and efficient in detecting low grade, low quality and duplicate pharmaceutical drugs in the market. The counterfeit drug detection devices offer superior quality services and protect the customers against frauds and fake products in the market. Counterfeit drugs can have a range of ill effects and side effects on the consumers and this is where the counterfeit drug detection devices assume their role.
Surging prevalence of chronic and acute diseases and infections in the population is one of the major factors responsible for fostering growth in the demand for counterfeit drug detection devices. In other words, growing incidence rate of skin disorder, chronic respiratory disease, asthma, musculoskeletal disorder, cancer and others is creative lucrative growth opportunities for the counterfeit drug detection devices market.
It is a fact of life that as the age grows, one becomes more vulnerable to developing diseases and infections. This indicates that increasing age is directly proportional to the increase in demand for drugs in the market. Since there is a wide scale availability of fake drugs and products in the market, this factor will propel growth in the demand for counterfeit drug detection devices.
The increase in the funding by the federal government is set to drive the demand for counterfeit drug detection devices. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities.
Additionally, surge in the personal disposable income level, rising awareness about the several side effects of counterfeit drugs and increasing investment for the development of advanced and innovative technology, positively affect the market growth rate.
Furthermore, upsurge in the public-private funding for target research activities and rising awareness of working people will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, surging focus of the government on the introduction of stringent norms and innovation of new medical devices and instruments will further expand the market's growth rate in the future.
On the other hand, high cost associated with the research and development proficiencies, lack of awareness in the underdeveloped economies, limited infrastructural facilities and dearth of skilled medical professionals and researchers are expected to obstruct market growth. Also, production of fake medicines in Myanmar region and loop holes in the hierarchy of packaging industry and sublimation of product while transportation are projected to challenge the market in the forecast period of 2022-2029.
This counterfeit drug detection device market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the counterfeit drug detection device market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 has had a positive impact on the counterfeit drug detection device market. In this pandemic phase, there was a high scale introduction of new medical products, devices and drugs in the market. This indicates that there was a subsequent availability of fake drugs and medicines. This led t the rise in demand for counterfeit drug detection devices from the pharmacies, healthcare institutions and end customers.
The counterfeit drug detection device market is segmented on the basis of product, modality, end use, drug assessment and therapeutic assessment. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
On the basis of product, the counterfeit drug detection device market is segmented into chemical composition detection devices, and packaging and labelling detection devices. Counterfeit chemical composition detection devices are further divided into ultraviolet/vis devices, infrared and near infrared spectroscopy devices, Raman spectrometers, and spectroscopy devices. Packaging and labelling detection devices is further sub-segmented into analyzers, scanning and imaging systems, and others.
On the basis of modality, the counterfeit drug detection device market is bifurcated into portable devices, handheld devices, and benchtop devices.
On the basis of end use, the counterfeit drug detection device market is segregated into pharmaceutical companies, drug testing laboratories, and research organizations.
On the basis of drug assessment, the counterfeit drug detection device market is segmented into oral pill, injectable, inhalable, topical, and eye drop.
On the basis of therapeutic assessment, the counterfeit drug detection device market is fragmented into alimentary, anti-infectives, blood agents, cardiovascular, central nervous system, cytostatics, dermatological, genitourinary, hormones, hospital solutions, metabolism, musculoskeletal, respiratory, other parasitology, and sensory organs.
The counterfeit drug detection device market is analysed and market size insights and trends are provided by country, product, modality, end use, drug assessment and therapeutic assessment as referenced above.
The countries covered in the counterfeit drug detection device market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the counterfeit drug detection device market because of the strong base of healthcare facilities, increasing number of toxicological laboratories, and the growing adoption of drug testing at the workplace.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, rising duplicity of medicines and drugs and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The counterfeit drug detection device market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for counterfeit drug detection device market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the counterfeit drug detection device market. The data is available for historic period 2010-2020.
The counterfeit drug detection device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to counterfeit drug detection device market.
Some of the major players operating in the counterfeit drug detection device market are Advanced Systems Development, Inc., B&W Tek., Centice Corporation, Consumer Physics, Global Pharma HealthCare Ltd., Olympus Corporation, PharmaSecure Inc., RIGAKU CORPORATION, Sproxil, Stratio, Inc., Thermo Fisher Scientific Inc., TSI Group Inc., Veripad, Bayer AG, Getinge AB, Midmark Corporation, STERIS, Abbott, GAO Group, Markem-Imaje and Spectral Engines GmbH among others.
SKU-
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL COUNTERFEIT DRUG DETECTION DEVICE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL COUNTERFEIT DRUG DETECTION DEVICES MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL COUNTERFEIT DRUG DETECTION DEVICES MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S 5 FORCES MODEL
5.3 STRATEGIC INITIATIVES
6 REGULATORY FRAMWORK
7 GLOBAL COUNTERFEIT DRUG DETECTION DEVICES, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 COUNTERFEIT CHEMICAL COMPOSITION DETECTION DEVICES
7.2.1 ULTRAVIOLET/VISIBLE DEVICE
7.2.1.1. BY TYPE
7.2.1.1.1. SINGLE BEAM
7.2.1.1.1.1 MARKET VALUE (US MN)
7.2.1.1.1.2 MARKET VOLUME (UNITS)
7.2.1.1.1.3 AVERAGE SELLING PRICE (USD)
7.2.1.1.2. SPLIT BEAM
7.2.1.1.2.1 MARKET VALUE (US MN)
7.2.1.1.2.2 MARKET VOLUME (UNITS)
7.2.1.1.2.3 AVERAGE SELLING PRICE (USD)
7.2.1.1.3. DOUBLE BEAM
7.2.1.1.3.1 MARKET VALUE (US MN)
7.2.1.1.3.2 MARKET VOLUME (UNITS)
7.2.1.1.3.3 AVERAGE SELLING PRICE (USD)
7.2.1.2. BY MODALITY
7.2.1.2.1. PORTABLE
7.2.1.2.1.1 CONTINUOUS DOSE UV-C LIGHT
7.2.1.2.1.1.1. MARKET VALUE (US MN)
7.2.1.2.1.1.2. MARKET VOLUME (UNITS)
7.2.1.2.1.1.3. AVERAGE SELLING PRICE (USD)
7.2.1.2.1.2 PULSED XENON LIGHT
7.2.1.2.1.2.1. MARKET VALUE (US MN)
7.2.1.2.1.2.2. MARKET VOLUME (UNITS)
7.2.1.2.1.2.3. AVERAGE SELLING PRICE (USD)
7.2.1.2.2. HANDHELD
7.2.1.2.2.1 MARKET VALUE (US MN)
7.2.1.2.2.2 MARKET VOLUME (UNITS)
7.2.1.2.2.3 AVERAGE SELLING PRICE (USD)
7.2.1.2.3. BENCHTOP
7.2.1.2.3.1 MARKET VALUE (US MN)
7.2.1.2.3.2 MARKET VOLUME (UNITS)
7.2.1.2.3.3 AVERAGE SELLING PRICE (USD)
7.2.2 MASS SPECTROMETERS
7.2.2.1. BY TYPE
7.2.2.1.1. MALDI_TOF
7.2.2.1.1.1 MARKET VALUE (US MN)
7.2.2.1.1.2 MARKET VOLUME (UNITS)
7.2.2.1.1.3 AVERAGE SELLING PRICE (USD)
7.2.2.1.2. ICP-MS
7.2.2.1.2.1 MARKET VALUE (US MN)
7.2.2.1.2.2 MARKET VOLUME (UNITS)
7.2.2.1.2.3 AVERAGE SELLING PRICE (USD)
7.2.2.1.3. DART-MS
7.2.2.1.3.1 MARKET VALUE (US MN)
7.2.2.1.3.2 MARKET VOLUME (UNITS)
7.2.2.1.3.3 AVERAGE SELLING PRICE (USD)
7.2.2.1.4. SIMS
7.2.2.1.4.1 MARKET VALUE (US MN)
7.2.2.1.4.2 MARKET VOLUME (UNITS)
7.2.2.1.4.3 AVERAGE SELLING PRICE (USD)
7.2.2.2. BY MODALITY
7.2.2.2.1. PORTABLE
7.2.2.2.1.1 MARKET VALUE (US MN)
7.2.2.2.1.2 MARKET VOLUME (UNITS)
7.2.2.2.1.3 AVERAGE SELLING PRICE (USD)
7.2.2.2.2. HANDHELD
7.2.2.2.2.1 MARKET VALUE (US MN)
7.2.2.2.2.2 MARKET VOLUME (UNITS)
7.2.2.2.2.3 AVERAGE SELLING PRICE (USD)
7.2.2.2.3. BENCHTOP
7.2.2.2.3.1 MARKET VALUE (US MN)
7.2.2.2.3.2 MARKET VOLUME (UNITS)
7.2.2.2.3.3 AVERAGE SELLING PRICE (USD)
7.2.3 NUCLEAR MAGNETIC RESONANCE
7.2.3.1. BY TYPE
7.2.3.1.1. CONTINUOUS WAVE NMR SPECTROMETER
7.2.3.1.1.1 MARKET VALUE (US MN)
7.2.3.1.1.2 MARKET VOLUME (UNITS)
7.2.3.1.1.3 AVERAGE SELLING PRICE (USD)
7.2.3.1.2. FOURIER TRANSFORM (FT-NMR)
7.2.3.1.2.1 MARKET VALUE (US MN)
7.2.3.1.2.2 MARKET VOLUME (UNITS)
7.2.3.1.2.3 AVERAGE SELLING PRICE (USD)
7.2.3.2. BY MODALITY
7.2.3.2.1. PORTABLE
7.2.3.2.1.1 MARKET VALUE (US MN)
7.2.3.2.1.2 MARKET VOLUME (UNITS)
7.2.3.2.1.3 AVERAGE SELLING PRICE (USD)
7.2.3.2.2. HANDHELD
7.2.3.2.2.1 MARKET VALUE (US MN)
7.2.3.2.2.2 MARKET VOLUME (UNITS)
7.2.3.2.2.3 AVERAGE SELLING PRICE (USD)
7.2.3.2.3. BENCHTOP
7.2.3.2.3.1 MARKET VALUE (US MN)
7.2.3.2.3.2 MARKET VOLUME (UNITS)
7.2.3.2.3.3 AVERAGE SELLING PRICE (USD)
7.2.4 INFRARED AND NEAR INFRARED SPECTROSCOPY DEVICE
7.2.4.1. BY TYPE
7.2.4.1.1. DISPERSIVE INFRARED SPECTROMETER
7.2.4.1.1.1 MARKET VALUE (US MN)
7.2.4.1.1.2 MARKET VOLUME (UNITS)
7.2.4.1.1.3 AVERAGE SELLING PRICE (USD)
7.2.4.1.2. FOURIER TRANSFORM INFRARED SPECTROMETER
7.2.4.1.2.1 MARKET VALUE (US MN)
7.2.4.1.2.2 MARKET VOLUME (UNITS)
7.2.4.1.2.3 AVERAGE SELLING PRICE (USD)
7.2.4.2. BY MODALITY
7.2.4.2.1. PORTABLE
7.2.4.2.1.1 MARKET VALUE (US MN)
7.2.4.2.1.2 MARKET VOLUME (UNITS)
7.2.4.2.1.3 AVERAGE SELLING PRICE (USD)
7.2.4.2.2. HANDHELD
7.2.4.2.2.1 MARKET VALUE (US MN)
7.2.4.2.2.2 MARKET VOLUME (UNITS)
7.2.4.2.2.3 AVERAGE SELLING PRICE (USD)
7.2.4.2.3. BENCHTOP
7.2.4.2.3.1 MARKET VALUE (US MN)
7.2.4.2.3.2 MARKET VOLUME (UNITS)
7.2.4.2.3.3 AVERAGE SELLING PRICE (USD)
7.2.5 RAMAN SPECTROMETERS
7.2.5.1. BY TYPE
7.2.5.1.1. CONFOCAL RAMAN SPECTROSCOPY
7.2.5.1.1.1 MARKET VALUE (US MN)
7.2.5.1.1.2 MARKET VOLUME (UNITS)
7.2.5.1.1.3 AVERAGE SELLING PRICE (USD)
7.2.5.1.2. MODULATED RAMAN SPECTROSCOPY
7.2.5.1.2.1 MARKET VALUE (US MN)
7.2.5.1.2.2 MARKET VOLUME (UNITS)
7.2.5.1.2.3 AVERAGE SELLING PRICE (USD)
7.2.5.1.3. SURFACE ENHANCED RAMAN SPECTROSCOPY
7.2.5.1.3.1 MARKET VALUE (US MN)
7.2.5.1.3.2 MARKET VOLUME (UNITS)
7.2.5.1.3.3 AVERAGE SELLING PRICE (USD)
7.2.5.1.4. TIP ENHANCED RAMAN SPECTROSCOPY
7.2.5.1.4.1 MARKET VALUE (US MN)
7.2.5.1.4.2 MARKET VOLUME (UNITS)
7.2.5.1.4.3 AVERAGE SELLING PRICE (USD)
7.2.5.2. BY MODALITY
7.2.5.2.1. PORTABLE
7.2.5.2.1.1 MARKET VALUE (US MN)
7.2.5.2.1.2 MARKET VOLUME (UNITS)
7.2.5.2.1.3 AVERAGE SELLING PRICE (USD)
7.2.5.2.2. HANDHELD
7.2.5.2.2.1 MARKET VALUE (US MN)
7.2.5.2.2.2 MARKET VOLUME (UNITS)
7.2.5.2.2.3 AVERAGE SELLING PRICE (USD)
7.2.5.2.3. BENCHTOP
7.2.5.2.3.1 MARKET VALUE (US MN)
7.2.5.2.3.2 MARKET VOLUME (UNITS)
7.2.5.2.3.3 AVERAGE SELLING PRICE (USD)
7.2.6 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)
7.2.6.1. BY TYPE
7.2.6.1.1. NORMAL PHASE HPLC COLUMNS
7.2.6.1.1.1 MARKET VALUE (US MN)
7.2.6.1.1.2 MARKET VOLUME (UNITS)
7.2.6.1.1.3 AVERAGE SELLING PRICE (USD)
7.2.6.1.2. REVERSE PHASE HPLC COLUMNS
7.2.6.1.2.1 MARKET VALUE (US MN)
7.2.6.1.2.2 MARKET VOLUME (UNITS)
7.2.6.1.2.3 AVERAGE SELLING PRICE (USD)
7.2.6.1.3. ION EXCHANGE HPLC COLUMNS
7.2.6.1.3.1 MARKET VALUE (US MN)
7.2.6.1.3.2 MARKET VOLUME (UNITS)
7.2.6.1.3.3 AVERAGE SELLING PRICE (USD)
7.2.6.1.4. SIZE EXCLUSION HPLC COLUMNS
7.2.6.1.4.1 MARKET VALUE (US MN)
7.2.6.1.4.2 MARKET VOLUME (UNITS)
7.2.6.1.4.3 AVERAGE SELLING PRICE (USD)
7.2.6.2. BY MODALITY
7.2.6.2.1. PORTABLE
7.2.6.2.1.1 MARKET VALUE (US MN)
7.2.6.2.1.2 MARKET VOLUME (UNITS)
7.2.6.2.1.3 AVERAGE SELLING PRICE (USD)
7.2.6.2.2. HANDHELD
7.2.6.2.2.1 MARKET VALUE (US MN)
7.2.6.2.2.2 MARKET VOLUME (UNITS)
7.2.6.2.2.3 AVERAGE SELLING PRICE (USD)
7.2.6.2.3. BENCHTOP
7.2.6.2.3.1 MARKET VALUE (US MN)
7.2.6.2.3.2 MARKET VOLUME (UNITS)
7.2.6.2.3.3 AVERAGE SELLING PRICE (USD)
7.2.7 GAS CHROMATOGRAPHY
7.2.7.1. BY TYPE
7.2.7.1.1. PACKED COLUMN
7.2.7.1.1.1 MARKET VALUE (US MN)
7.2.7.1.1.2 MARKET VOLUME (UNITS)
7.2.7.1.1.3 AVERAGE SELLING PRICE (USD)
7.2.7.1.2. CAPILLARY COLUMN
7.2.7.1.2.1 MARKET VALUE (US MN)
7.2.7.1.2.2 MARKET VOLUME (UNITS)
7.2.7.1.2.3 AVERAGE SELLING PRICE (USD)
7.2.7.2. BY MODALITY
7.2.7.2.1. PORTABLE
7.2.7.2.1.1 MARKET VALUE (US MN)
7.2.7.2.1.2 MARKET VOLUME (UNITS)
7.2.7.2.1.3 AVERAGE SELLING PRICE (USD)
7.2.7.2.2. HANDHELD
7.2.7.2.2.1 MARKET VALUE (US MN)
7.2.7.2.2.2 MARKET VOLUME (UNITS)
7.2.7.2.2.3 AVERAGE SELLING PRICE (USD)
7.2.7.2.3. BENCHTOP
7.2.7.2.3.1 MARKET VALUE (US MN)
7.2.7.2.3.2 MARKET VOLUME (UNITS)
7.2.7.2.3.3 AVERAGE SELLING PRICE (USD)
7.2.8 THIN LAYER CHROMATOGRAPH
7.2.8.1. BY TYPE
7.2.8.1.1. HPTLC
7.2.8.1.1.1 MARKET VALUE (US MN)
7.2.8.1.1.2 MARKET VOLUME (UNITS)
7.2.8.1.1.3 AVERAGE SELLING PRICE (USD)
7.2.8.1.2. PLC
7.2.8.1.2.1 MARKET VALUE (US MN)
7.2.8.1.2.2 MARKET VOLUME (UNITS)
7.2.8.1.2.3 AVERAGE SELLING PRICE (USD)
7.2.8.1.3. TLC-MS
7.2.8.1.3.1 MARKET VALUE (US MN)
7.2.8.1.3.2 MARKET VOLUME (UNITS)
7.2.8.1.3.3 AVERAGE SELLING PRICE (USD)
7.2.8.2. BY MODALITY
7.2.8.2.1. PORTABLE
7.2.8.2.1.1 MARKET VALUE (US MN)
7.2.8.2.1.2 MARKET VOLUME (UNITS)
7.2.8.2.1.3 AVERAGE SELLING PRICE (USD)
7.2.8.2.2. HANDHELD
7.2.8.2.2.1 MARKET VALUE (US MN)
7.2.8.2.2.2 MARKET VOLUME (UNITS)
7.2.8.2.2.3 AVERAGE SELLING PRICE (USD)
7.2.8.2.3. BENCHTOP
7.2.8.2.3.1 MARKET VALUE (US MN)
7.2.8.2.3.2 MARKET VOLUME (UNITS)
7.2.8.2.3.3 AVERAGE SELLING PRICE (USD)
7.2.9 XRD & XRF SPECTROSCOPY DEVICE
7.2.9.1. BY TYPE
7.2.9.1.1. CCD X-RAY DETECTOR
7.2.9.1.1.1 MARKET VALUE (US MN)
7.2.9.1.1.2 MARKET VOLUME (UNITS)
7.2.9.1.1.3 AVERAGE SELLING PRICE (USD)
7.2.9.1.2. ENERGY DISPERSIVE XRF SECTROMETER
7.2.9.1.2.1 MARKET VALUE (US MN)
7.2.9.1.2.2 MARKET VOLUME (UNITS)
7.2.9.1.2.3 AVERAGE SELLING PRICE (USD)
7.2.9.1.3. HANDHELD XRF ANALYZER
7.2.9.1.3.1 MARKET VALUE (US MN)
7.2.9.1.3.2 MARKET VOLUME (UNITS)
7.2.9.1.3.3 AVERAGE SELLING PRICE (USD)
7.2.9.1.4. WDXRF SPECTROMETER
7.2.9.1.4.1 MARKET VALUE (US MN)
7.2.9.1.4.2 MARKET VOLUME (UNITS)
7.2.9.1.4.3 AVERAGE SELLING PRICE (USD)
7.2.9.1.5. X-RAY CRYSTALLOGRAPHY
7.2.9.1.5.1 MARKET VALUE (US MN)
7.2.9.1.5.2 MARKET VOLUME (UNITS)
7.2.9.1.5.3 AVERAGE SELLING PRICE (USD)
7.2.9.2. BY MODALITY
7.2.9.2.1. PORTABLE
7.2.9.2.1.1 MARKET VALUE (US MN)
7.2.9.2.1.2 MARKET VOLUME (UNITS)
7.2.9.2.1.3 AVERAGE SELLING PRICE (USD)
7.2.9.2.2. HANDHELD
7.2.9.2.2.1 MARKET VALUE (US MN)
7.2.9.2.2.2 MARKET VOLUME (UNITS)
7.2.9.2.2.3 AVERAGE SELLING PRICE (USD)
7.2.9.2.3. BENCHTOP
7.2.9.2.3.1 MARKET VALUE (US MN)
7.2.9.2.3.2 MARKET VOLUME (UNITS)
7.2.9.2.3.3 AVERAGE SELLING PRICE (USD)
7.2.10 OTHERS
7.3 COUNTERFEIT PACKAGING AND LABELLING DETECTION
7.3.1 RFID ANALYZERS
7.3.1.1. BY TYPE
7.3.1.1.1. ACTIVE RFID ANALYZER
7.3.1.1.1.1 MARKET VALUE (US MN)
7.3.1.1.1.2 MARKET VOLUME (UNITS)
7.3.1.1.1.3 AVERAGE SELLING PRICE (USD)
7.3.1.1.2. SEMI PASSIVE RFID ANALYZER
7.3.1.1.2.1 MARKET VALUE (US MN)
7.3.1.1.2.2 MARKET VOLUME (UNITS)
7.3.1.1.2.3 AVERAGE SELLING PRICE (USD)
7.3.1.1.3. PASSIVE RFID ANALYZER
7.3.1.1.3.1 MARKET VALUE (US MN)
7.3.1.1.3.2 MARKET VOLUME (UNITS)
7.3.1.1.3.3 AVERAGE SELLING PRICE (USD)
7.3.1.2. BY MODALITY
7.3.1.2.1. PORTABLE
7.3.1.2.1.1 MARKET VALUE (US MN)
7.3.1.2.1.2 MARKET VOLUME (UNITS)
7.3.1.2.1.3 AVERAGE SELLING PRICE (USD)
7.3.1.2.2. HANDHELD
7.3.1.2.2.1 MARKET VALUE (US MN)
7.3.1.2.2.2 MARKET VOLUME (UNITS)
7.3.1.2.2.3 AVERAGE SELLING PRICE (USD)
7.3.1.2.3. BENCHTOP
7.3.1.2.3.1 MARKET VALUE (US MN)
7.3.1.2.3.2 MARKET VOLUME (UNITS)
7.3.1.2.3.3 AVERAGE SELLING PRICE (USD)
7.3.2 SCANNING AND IMAGING SYSTEMS
7.3.2.1. BY TYPE
7.3.2.1.1. FT-IR IMAGING SYSTEM
7.3.2.1.1.1 MARKET VALUE (US MN)
7.3.2.1.1.2 MARKET VOLUME (UNITS)
7.3.2.1.1.3 AVERAGE SELLING PRICE (USD)
7.3.2.1.2. TRUSCAN
7.3.2.1.2.1 MARKET VALUE (US MN)
7.3.2.1.2.2 MARKET VOLUME (UNITS)
7.3.2.1.2.3 AVERAGE SELLING PRICE (USD)
7.3.2.1.3. TRUTAG
7.3.2.1.3.1 MARKET VALUE (US MN)
7.3.2.1.3.2 MARKET VOLUME (UNITS)
7.3.2.1.3.3 AVERAGE SELLING PRICE (USD)
7.3.2.2. BY MODALITY
7.3.2.2.1. PORTABLE
7.3.2.2.1.1 MARKET VALUE (US MN)
7.3.2.2.1.2 MARKET VOLUME (UNITS)
7.3.2.2.1.3 AVERAGE SELLING PRICE (USD)
7.3.2.2.2. HANDHELD
7.3.2.2.2.1 MARKET VALUE (US MN)
7.3.2.2.2.2 MARKET VOLUME (UNITS)
7.3.2.2.2.3 AVERAGE SELLING PRICE (USD)
7.3.2.2.3. BENCHTOP
7.3.2.2.3.1 MARKET VALUE (US MN)
7.3.2.2.3.2 MARKET VOLUME (UNITS)
7.3.2.2.3.3 AVERAGE SELLING PRICE (USD)
7.3.3 OTHERS
8 GLOBAL COUNTERFEIT DRUG DETECTION DEVICE MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 MISLABELED MEDICATION
8.2.1 RFID ANALYZERS
8.2.2 SCANNING AND IMAGING SYSTEMS
8.2.3 OTHERS
8.3 INCORRECT DOSE OF THE ACTIVE INGREDIENT
8.3.1 MASS SPECTROMETER
8.3.2 RAMAN SPECTROMETER
8.3.3 OTHERS
8.4 ACTIVE DRUG PRESENCE
8.4.1 THIN LAYER CHROMATOGRAPHY
8.4.2 HPLC
8.4.3 GAS CHROMATOGRAPHY
8.4.4 OT
8.5 HARMFUL SUBSTANCE PRESENCE
8.5.1 UV/VISIBLE SPECTROMETER
8.5.2 NMR SPECTROSCOPY
8.6 UNLISTED ACTIVE INGREDIENT
8.6.1 GAS CHROMATOGRAPHY
8.6.2 XRF & XRD SPECTROSCOPY DEVICE
8.6.3 INFRARED SPECTROSCOPY DEVICE
8.7 OTHERS
9 GLOBAL COUNTERFEIT DRUG DETECTION DEVICE MARKET, BY DRUG ASSESSMENT
9.1 ORAL PILLS
9.2 INJECTABLES
9.3 INHALABLE
9.4 TOPICAL SOLUTIONS
9.5 EYE DROPS
9.6 OTHERS
10 GLOBAL COUNTERFEIT DRUG DETECTION DEVICE MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL COMPANIES
10.3 DRUG TESTING LABORATORIES
10.4 RESEARCH ORGANIZATION
10.5 GOVERNMENT AUTHORITIES
10.6 OTHERS
11 GLOBAL COUNTERFEIT DRUG DETECTION DEVICE MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
12 GLOBAL COUNTERFEIT DRUG DETECTION DEVICE MARKET, BY REGION
12.1 GLOBAL COUNTERFEIT DRUG DETECTION DEVICE MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
12.2 NORTH AMERICA
12.2.1 U.S.
12.2.1.1. U.S. COUNTERFEIT DRUG DETECTION DEVICE MARKET,BY PRODUCT
12.2.1.2. U.S.COUNTERFEIT DRUG DETECTION DEVICE MARKET,BY MODALITY
12.2.1.3. U.S.COUNTERFEIT DRUG DETECTION DEVICE MARKET,BY APPLICATION
12.2.1.4. U.S.COUNTERFEIT DRUG DETECTION DEVICE MARKET,BY DRUG ASSESSMENT
12.2.1.5. U.S. COUNTERFEIT DRUG DETECTION DEVICE MARKET,BY END USER
12.2.1.6. U.S.COUNTERFEIT DRUG DETECTION DEVICE MARKET,BY DISTRIBUTION CHANNEL
12.2.2 CANADA
12.2.3 MEXICO
12.3 EUROPE
12.3.1 GERMANY
12.3.2 FRANCE
12.3.3 U.K.
12.3.4 HUNGARY
12.3.5 LITHUANIA
12.3.6 AUSTRIA
12.3.7 IRELAND
12.3.8 NORWAY
12.3.9 POLAND
12.3.10 ITALY
12.3.11 SPAIN
12.3.12 RUSSIA
12.3.13 TURKEY
12.3.14 NETHERLANDS
12.3.15 SWITZERLAND
12.3.16 REST OF EUROPE
12.4 ASIA-PACIFIC
12.4.1 JAPAN
12.4.2 CHINA
12.4.3 TAIWAN
12.4.4 SOUTH KOREA
12.4.5 INDIA
12.4.6 AUSTRALIA
12.4.7 SINGAPORE
12.4.8 THAILAND
12.4.9 MALAYSIA
12.4.10 INDONESIA
12.4.11 PHILIPPINES
12.4.12 VIETNAM
12.4.13 REST OF ASIA-PACIFIC
12.5 SOUTH AMERICA
12.5.1 BRAZIL
12.5.2 ECUADOR
12.5.3 CHILE
12.5.4 COLOMBIA
12.5.5 VENEZUELA
12.5.6 ARGENTINA
12.5.7 PERU
12.5.8 REST OF SOUTH AMERICA
12.6 MIDDLE EAST AND AFRICA
12.6.1 SOUTH AFRICA
12.6.2 SAUDI ARABIA
12.6.3 UAE
12.6.4 EGYPT
12.6.5 KUWAIT
12.6.6 ISRAEL
12.6.7 REST OF MIDDLE EAST AND AFRICA
12.7 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
13 GLOBAL COUNTERFEIT DRUG DETECTION DEVICE MARKET, SWOT AND DBMR ANALYSIS
14 GLOBAL COUNTERFEIT DRUG DETECTION DEVICE MARKET, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
14.3 COMPANY SHARE ANALYSIS: EUROPE
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14.5 MERGERS & ACQUISITIONS
14.6 NEW PRODUCT DEVELOPMENT & APPROVALS
14.7 EXPANSIONS
14.8 REGULATORY CHANGES
14.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
15 GLOBAL COUNTERFEIT DRUG DETECTION DEVICE MARKET, COMPANY PROFILE
15.1 BRUKER
15.1.1 COMPANY OVERVIEW
15.1.2 REVELUE ANALYSIS
15.1.3 GEOGRAPHIC PRESENCE
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPEMENTS
15.2 AGILENT
15.2.1 COMPANY OVERVIEW
15.2.2 REVENUE ANALYSIS
15.2.3 GEOGRAPHIC PRESENCE
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPEMENTS
15.3 METTLER TOLEDO
15.3.1 COMPANY OVERVIEW
15.3.2 REVENUE ANALYSIS
15.3.3 GEOGRAPHIC PRESENCE
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPEMENTS
15.4 SHIMADZU CORPORATION
15.4.1 COMPANY OVERVIEW
15.4.2 REVENUE ANALYSIS
15.4.3 GEOGRAPHIC PRESENCE
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPEMENTS
15.5 HITACHI HIGH-TECH CORPORATION
15.5.1 COMPANY OVERVIEW
15.5.2 REVNUE ANALYSIS
15.5.3 GEOGRAPHIC PRESENCE
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPEMENTS
15.6 PERKINELMER INC
15.6.1 COMPANY OVERVIEW
15.6.2 REVENUE ANALYSIS
15.6.3 GEOGRAPHIC PRESENCE
15.6.4 PRODUCT PORTFOLIO
15.6.5 RECENT DEVELOPEMENTS
15.7 THERMO FISHER SCIENTIFIC
15.7.1 COMPANY OVERVIEW
15.7.2 REVENUE ANALYSIS
15.7.3 GEOGRAPHIC PRESENCE
15.7.4 PRODUCT PORTFOLIO
15.7.5 RECENT DEVELOPEMENTS
15.8 SCIEX
15.8.1 COMPANY OVERVIEW
15.8.2 REVENUE ANALYSIS
15.8.3 GEOGRAPHIC PRESENCE
15.8.4 PRODUCT PORTFOLIO
15.8.5 RECENT DEVELOPEMENTS
15.9 WATERS
15.9.1 COMPANY OVERVIEW
15.9.2 REVENUE ANALYSIS
15.9.3 GEOGRAPHIC PRESENCE
15.9.4 PRODUCT PORTFOLIO
15.9.5 RECENT DEVELOPEMENTS
15.1 ANALYTIK JENA GMBH
15.10.1 COMPANY OVERVIEW
15.10.2 REVENUE ANALYSIS
15.10.3 GEOGRAPHIC PRESENCE
15.10.4 PRODUCT PORTFOLIO
15.10.5 RECENT DEVELOPEMENTS
15.11 JEOL LTD
15.11.1 COMPANY OVERVIEW
15.11.2 REVENUE ANALYSIS
15.11.3 GEOGRAPHIC PRESENCE
15.11.4 PRODUCT PORTFOLIO
15.11.5 RECENT DEVELOPEMENTS
15.12 HORIBA
15.12.1 COMPANY OVERVIEW
15.12.2 REVENUE ANALYSIS
15.12.3 GEOGRAPHIC PRESENCE
15.12.4 PRODUCT PORTFOLIO
15.12.5 RECENT DEVELOPEMENTS
15.13 JASCO
15.13.1 COMPANY OVERVIEW
15.13.2 REVENUE ANALYSIS
15.13.3 GEOGRAPHIC PRESENCE
15.13.4 PRODUCT PORTFOLIO
15.13.5 RECENT DEVELOPEMENTS
15.14 RENISHAW
15.14.1 COMPANY OVERVIEW
15.14.2 REVENUE ANALYSIS
15.14.3 GEOGRAPHIC PRESENCE
15.14.4 PRODUCT PORTFOLIO
15.14.5 RECENT DEVELOPEMENTS
15.15 MCPHERSON
15.15.1 COMPANY OVERVIEW
15.15.2 REVENUE ANALYSIS
15.15.3 GEOGRAPHIC PRESENCE
15.15.4 PRODUCT PORTFOLIO
15.15.5 RECENT DEVELOPEMENTS
15.16 APPLIED RIGAKU TECHNOLOGIES, INC
15.16.1 COMPANY OVERVIEW
15.16.2 REVENUE ANALYSIS
15.16.3 GEOGRAPHIC PRESENCE
15.16.4 PRODUCT PORTFOLIO
15.16.5 RECENT DEVELOPEMENTS
15.17 EVIDENT
15.17.1 COMPANY OVERVIEW
15.17.2 REVENUE ANALYSIS
15.17.3 GEOGRAPHIC PRESENCE
15.17.4 PRODUCT PORTFOLIO
15.17.5 RECENT DEVELOPEMENTS
15.18 GENERAL ELECTRONIC
15.18.1 COMPANY OVERVIEW
15.18.2 REVENUE ANALYSIS
15.18.3 GEOGRAPHIC PRESENCE
15.18.4 PRODUCT PORTFOLIO
15.18.5 RECENT DEVELOPEMENTS
15.19 BIO-RAD LABORATORIES, INC
15.19.1 COMPANY OVERVIEW
15.19.2 REVENUE ANALYSIS
15.19.3 GEOGRAPHIC PRESENCE
15.19.4 PRODUCT PORTFOLIO
15.19.5 RECENT DEVELOPEMENTS
15.2 SHOWA DENKO K.K
15.20.1 COMPANY OVERVIEW
15.20.2 REVENUE ANALYSIS
15.20.3 GEOGRAPHIC PRESENCE
15.20.4 PRODUCT PORTFOLIO
15.20.5 RECENT DEVELOPEMENTS
15.21 ANASAZI INSTRUMENTS INC
15.21.1 COMPANY OVERVIEW
15.21.2 REVENUE ANALYSIS
15.21.3 GEOGRAPHIC PRESENCE
15.21.4 PRODUCT PORTFOLIO
15.21.5 RECENT DEVELOPEMENTS
15.22 NIUMAG CORPORATION
15.22.1 COMPANY OVERVIEW
15.22.2 REVENUE ANALYSIS
15.22.3 GEOGRAPHIC PRESENCE
15.22.4 PRODUCT PORTFOLIO
15.22.5 RECENT DEVELOPEMENTS
15.23 OXFORD INSTRUMENTS
15.23.1 COMPANY OVERVIEW
15.23.2 REVENUE ANALYSIS
15.23.3 GEOGRAPHIC PRESENCE
15.23.4 PRODUCT PORTFOLIO
15.23.5 RECENT DEVELOPEMENTS
15.24 GBC SCIENTIFIC EQUIPMENTS
15.24.1 COMPANY OVERVIEW
15.24.2 REVENUE ANALYSIS
15.24.3 GEOGRAPHIC PRESENCE
15.24.4 PRODUCT PORTFOLIO
15.24.5 RECENT DEVELOPEMENTS
15.25 BUCK SCIENTIFIC
15.25.1 COMPANY OVERVIEW
15.25.2 REVENUE ANALYSIS
15.25.3 GEOGRAPHIC PRESENCE
15.25.4 PRODUCT PORTFOLIO
15.25.5 RECENT DEVELOPEMENTS
15.26 COLE-PARM
15.26.1 COMPANY OVERVIEW
15.26.2 REVENUE ANALYSIS
15.26.3 GEOGRAPHIC PRESENCE
15.26.4 PRODUCT PORTFOLIO
15.26.5 RECENT DEVELOPEMENTS
15.27 SPECTRIS
15.27.1 COMPANY OVERVIEW
15.27.2 REVENUE ANALYSIS
15.27.3 GEOGRAPHIC PRESENCE
15.27.4 PRODUCT PORTFOLIO
15.27.5 RECENT DEVELOPEMENTS
15.28 DANAHER CORPORATION
15.28.1 COMPANY OVERVIEW
15.28.2 REVENUE ANALYSIS
15.28.3 GEOGRAPHIC PRESENCE
15.28.4 PRODUCT PORTFOLIO
15.28.5 RECENT DEVELOPEMENTS
15.29 NOVASEP HOLDING S.A.S
15.29.1 COMPANY OVERVIEW
15.29.2 REVENUE ANALYSIS
15.29.3 GEOGRAPHIC PRESENCE
15.29.4 PRODUCT PORTFOLIO
15.29.5 RECENT DEVELOPEMENTS
15.3 TOSOH CORPORATION
15.30.1 COMPANY OVERVIEW
15.30.2 REVENUE ANALYSIS
15.30.3 GEOGRAPHIC PRESENCE
15.30.4 PRODUCT PORTFOLIO
15.30.5 RECENT DEVELOPEMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
16 RELATED REPORTS
17 CONCLUSION
18 QUESTIONNAIRE
19 ABOUT DATA BRIDGE MARKET RESEARCH
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.